Diets in Oncology

WHY THIS ENTRY EXISTS AT ALL

Alcohol is rarely treated as a nutritional factor with oncological significance, yet it is one of the best documented. The International Agency for Research on Cancer (IARC) classifies it as a Group 1 carcinogen — the highest category, which also contains asbestos, ionising radiation and tobacco ^[2].

FOR WHICH CANCERS THE LINK IS CAUSAL

The NCI lists cancers of the oral cavity and throat, larynx, oesophagus (squamous cell form), liver, colorectum and breast ^[1]. Risk figures relative to non-drinkers, as given by the NCI ^[1]:

• oral cavity and throat: 1.1 times in light drinkers, 5 times in heavy drinkers;
• oesophagus (squamous cell): 1.3 times in light drinkers, 5 times in heavy drinkers;
• liver: 2 times in heavy drinkers;
• breast: 1.04 times in light, 1.23 times in moderate, 1.6 times in heavy drinkers;
• colorectum: 1.2 to 1.5 times in moderate to heavy drinkers.

IS THERE A SAFE DOSE

WHO answers plainly that there is not: "there is no safe amount that does not affect health", and the risk "starts from the first drop" ^[3]. This is not rhetoric — WHO states that half of alcohol-attributable cancers in the European Region arise from light and moderate consumption (less than 1.5 litres of wine, 3.5 litres of beer or 450 ml of spirits weekly), and that this very pattern accounts for the majority of alcohol-attributable breast cancers in women ^[3].

HOW ALCOHOL DAMAGES CELLS

The NCI points to several parallel mechanisms ^[1]: conversion of ethanol to acetaldehyde, a carcinogen that damages DNA; generation of reactive oxygen species and oxidative damage; impaired absorption of nutrients; increased absorption of other carcinogens (which explains the overlap between alcohol and tobacco); raised oestrogen levels; disrupted folate metabolism.

WHAT STOPPING ACHIEVES

The NCI states that discontinuing alcohol reduces the risk of cancers of the mouth, throat, oesophagus, breast and colorectum, while noting that "it may take years for the risks of cancer to return to those of never drinkers" — and adding that it is never too late to stop ^[1].

WHAT THESE DATA DO NOT SAY

They do not say that, in someone already under cancer treatment, stopping alcohol replaces any part of that treatment; the figures quoted concern the RISK OF DEVELOPING cancer, not the treatment of diagnosed disease. Nor do they establish how large the effect is in an individual — these are population-level risks, overlaid by tobacco use, family history and other factors. Decisions about management of cancer are made by the specialist physician.

Sources

1. National Cancer Institute — Alcohol and Cancer Risk (Fact Sheet): cancer.gov ↗
2. IARC Monographs on the Identification of Carcinogenic Hazards to Humans — Alcohol consumption, Group 1 (via WHO/Europe): who.int ↗
3. World Health Organization, Regional Office for Europe — No level of alcohol consumption is safe for our health (2023): who.int ↗

WHAT EXACTLY IARC ASSESSED

In October 2015 a working group of the International Agency for Research on Cancer assessed two separate things ^[1]:

• PROCESSED MEAT — meat transformed through salting, curing, fermentation, smoking or other processes to enhance flavour or preservation (sausages, ham, cured and canned meats, dried meat): GROUP 1, the category of agents carcinogenic to humans. The basis was SUFFICIENT EVIDENCE from epidemiological studies that eating it causes colorectal cancer ^[1];
• RED MEAT — unprocessed mammalian muscle meat (beef, veal, pork, lamb, mutton, horse, goat): GROUP 2A, probably carcinogenic to humans. Here the epidemiological evidence was LIMITED — positive associations with colorectal cancer were seen, but other explanations could not be ruled out; strong mechanistic evidence tipped the assessment ^[1].

WHAT "GROUP 1" DOES NOT MEAN. Group 1 speaks to the STRENGTH OF EVIDENCE that something causes cancer, not to the SIZE OF THE RISK. Tobacco smoke sits in the same group, but — as IARC itself stresses — this does not make a slice of ham as dangerous as a cigarette ^[1]. The classification answers "does it cause cancer", not "by how much".

SO BY HOW MUCH DOES RISK RISE

WHO gives one concrete figure: each 50 g portion of processed meat eaten daily increases the risk of colorectal cancer by about 18% ^[1]. This is a RELATIVE risk — an increase measured from a person's baseline risk, not 18 extra cases per hundred people. For red meat no comparable firm figure was given, because the evidence is limited ^[1].

IS THERE A SAFE PORTION

WHO states that the available data DID NOT PERMIT a conclusion on whether a risk-free level of consumption exists ^[1]. That is neither confirmation nor denial of a safety threshold — it is an honest statement of the limit of current knowledge.

WHAT FOLLOWS IN PRACTICE

WHO does not issue its own dietary recommendations here — it notes that national governments and health agencies do — but recalls its 2002 position: people who eat meat should moderate their consumption of processed meat in order to reduce the risk of colorectal cancer ^[1]. WHO also notes that red meat has nutritional value (protein, iron, zinc, vitamin B12), so weighing risks against benefits is a matter for national health authorities ^[1].

WHAT THIS ENTRY DOES NOT SAY

It does not say how any individual should eat — whether healthy or ill. The figures quoted concern the RISK OF DEVELOPING cancer in a population, not the treatment of diagnosed disease or diet during therapy. Nor does it say that avoiding meat guarantees freedom from colorectal cancer: risk also reflects family history, age, obesity, physical activity, tobacco and alcohol. Decisions about nutrition during cancer are made by the treating physician together with a clinical dietitian.

Sources

1. World Health Organization — Q&A: Cancer, carcinogenicity of the consumption of red meat and processed meat (IARC Monographs Volume 114): who.int ↗

STRENGTH OF THE EVIDENCE

In the World Cancer Research Fund classification only a few dietary factors reach the top grade. Fibre and wholegrains are among them: the expert panel grades as strong the evidence that wholegrains DECREASE the risk of colorectal cancer, and that foods containing dietary fibre decrease that risk and protect against weight gain ^[1]. In the previous edition of the report the evidence for fibre was graded probable - after review of new data it was upgraded ^[1].

NUMBERS FROM THE META-ANALYSIS

• 25 prospective studies, dose-response analysis ^[2];
• per 10 g of total dietary fibre per day: relative risk 0.90 (95% CI 0.86-0.94), 16 studies ^[2];
• per three servings of wholegrains per day (about 90 g): relative risk 0.83 (95% CI 0.78-0.89), 6 studies ^[2];
• in practice this is a graded relationship: the benefit grows with intake, with no clear threshold at which it begins.

WHERE THE EFFECT MAY COME FROM

WCRF names two main mechanisms. Fibre is fermented by colonic microflora into short-chain fatty acids, including butyrate, which in experimental studies inhibits proliferation of colon cancer cells. The second mechanism is mechanical: fibre shortens intestinal transit time and increases faecal bulk, so potential faecal mutagens have less time in contact with the mucosa ^[1].

TRANSLATING THIS INTO A DIET

• the WCRF recommendation: at least 30 g of fibre a day and at least 400 g of a variety of non-starchy vegetables and fruit a day ^[1];
• sources are wholegrain bread and pasta, groats (buckwheat, barley, oat), brown rice, pulses, vegetables and fruit;
• the recommendation speaks explicitly of fibre FROM FOOD - not of fibre supplements, for which no such cancer-risk data exist;
• the same dietary factor works in a second direction: fibre-rich food protects against weight gain, and excess body weight is a separate, documented risk factor for many cancers ^[1].

WHAT THESE DATA DO NOT SAY

All the cited results come from observational studies of prevention: they concern the risk of DEVELOPING cancer in healthy people. They are not evidence that increasing fibre intake after a cancer diagnosis affects the course of the disease, recurrence or survival. People who eat a lot of fibre also differ from others in other health behaviours, and despite statistical adjustment that influence cannot be fully separated out.

WHEN FIBRE MAY BE CONTRAINDICATED

This is the most important caveat for a reader who is ill rather than healthy. A high-residue diet is not right for everyone: with narrowing or threatened obstruction of the gastrointestinal tract, in the perioperative period after bowel surgery, with a stoma in the early period after formation, during and after pelvic radiotherapy complicated by enteritis, and in severe diarrhoea after treatment - in these situations a diet with the OPPOSITE profile, low-residue, is often advised. This is decided by the treating team together with a clinical dietitian, not by a general prevention recommendation.

Sources

1. [1] World Cancer Research Fund — Eat a diet rich in wholegrains, vegetables, fruit and beans: evidence for our recommendations (mocne dowody dla raka jelita grubego, cel 30 g błonnika dziennie): wcrf.org ↗
2. [2] Aune D i wsp. — Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies, BMJ 2011 (25 badań prospektywnych, PMID 22074852): europepmc.org ↗
3. [3] World Cancer Research Fund — Diet, nutrition, physical activity and colorectal cancer (raport przeglądowy Continuous Update Project): wcrf.org ↗

WHAT EXACTLY IS PROVEN

WCRF frames it as strong evidence that certain high-salt foods are a cause of stomach cancer, and names them: foods preserved by salting, such as meat and fish, and salt-preserved vegetables ^[1]. The more of these foods a person eats, the greater their chance of developing the disease ^[1].

WHAT IS NOT PROVEN - THE MOST COMMONLY CONFUSED PART: The evidence on total dietary salt intake is weaker. WCRF states plainly that studies covering populations worldwide did NOT show a strong link between total salt intake and stomach cancer ^[1]. A statement about the salt cellar and a statement about salted and fermented preserves are not the same statement and do not carry the same evidential weight.

WHERE THESE DATA COME FROM

The main studies were conducted in Asia, above all in Japan and Korea, because in those culinary traditions many foods are preserved by salting and fermentation rather than by refrigeration as in most Western countries ^[1]. This matters directly for a reader in Poland: the intakes observed in those studies are far higher than is typical of a Central European diet, so transferring the result to a Polish menu is an approximation rather than direct data.

PROPOSED MECHANISM

Salt damages the stomach lining and causes lesions which, if left to develop, can become stomach cancer ^[1]. A second strand concerns Helicobacter pylori infection - its effect is made worse in the presence of salt ^[1]. H. pylori infection is a separate, well-documented risk factor for stomach cancer and is the principal factor in this diagnosis, not diet.

A SEPARATE ITEM - CANTONESE-STYLE SALTED FISH

The International Agency for Research on Cancer (IARC) found sufficient evidence that Chinese-style salted fish causes cancer of the nasopharynx, and sufficient evidence linking it with stomach cancer ^[2]. This is a distinct product category singled out by IARC, not a general statement about fish.

WHAT FOLLOWS IN PRACTICE

• WCRF made no global recommendation on salt-preserved foods, because these products are eaten mainly in Asia; the expert panel nevertheless advises that it is best not to consume them ^[1];
• on salt itself, WCRF points to the World Health Organization threshold: below 5 g of salt a day ^[1]. This is a public health recommendation, framed mainly around blood pressure, not an oncological recommendation for an individual;
• preserving food by refrigeration instead of salting is the element that changed the risk picture in Western countries.

WHAT THIS ENTRY DOES NOT SAY

All the evidence cited concerns PREVENTION - the risk of developing cancer in healthy people. It is not data on the effect of reducing salt on the course of a diagnosed cancer, on recurrence or on survival. In patients undergoing cancer treatment the diet is often modified for entirely different reasons (loss of appetite, altered taste, risk of malnutrition, coexisting heart and kidney disease), and those modifications are decided by the treating team together with a clinical dietitian, not by a general prevention recommendation.

Sources

1. [1] World Cancer Research Fund — Salt: shaking up the link with stomach cancer (mocne dowody dla żywności konserwowanej solą; brak silnego związku dla całkowitego spożycia soli; próg WHO 5 g dziennie): wcrf.org ↗
2. [2] World Cancer Research Fund — Limit red and processed meat: evidence for our recommendations (stanowisko IARC: solona ryba w stylu chińskim a rak nosogardła i rak żołądka): wcrf.org ↗

TWO RESULTS THAT DO NOT ADD UP TO ONE RECOMMENDATION:

• colorectal cancer: WCRF grades as strong the evidence that dairy products DECREASE the risk, and separately that taking calcium supplements decreases it too ^[1];
• prostate cancer: there is evidence that higher consumption of dairy products MAY INCREASE the risk of this cancer, and that diets high in calcium may increase it ^[1]; this evidence is weaker than that for colorectal cancer and is stated in conditional terms;
• the consequence for recommendations: WCRF did not include dairy among its Cancer Prevention Recommendations precisely because the balance differs between cancers ^[1].

WHY THIS MATTERS RATHER THAN MERELY BEING INTERESTING

A reader looking for a single answer to whether dairy is good or bad will not find one - not because science has yet to catch up, but because the answer depends on which cancer is meant. The institution that has been collecting these data for decades concluded that the most honest course was to issue no recommendation. Publications that present dairy unambiguously, either as protective or as a threat, omit half of the evidence.

PROPOSED MECHANISM

The protective effect of dairy against colorectal cancer is linked above all to its calcium content ^[1]. That same component, however, is suspected of contributing to the second, opposite signal concerning the prostate ^[1]. These are not two independent strands but one component assessed in two different organs.

ON CALCIUM SUPPLEMENTS

WCRF extends the strong evidence of reduced colorectal cancer risk to calcium supplements as well ^[1]. We give no doses or dosing schedule here: that would be advice for an individual rather than a description of the state of knowledge, and with calcium the decision has to take account of factors outside oncology (kidney stones, kidney disease, concurrent medication). Separately we repeat the general rule: the treating physician should be told about all supplements being taken.

WHAT THIS ENTRY DOES NOT SAY

All the evidence cited concerns PREVENTION - the risk of developing cancer in healthy people. It is not data on the effect of dairy intake on the course of a diagnosed cancer, on recurrence or on survival. Nor does it address situations in which dairy is restricted for entirely different reasons: lactose intolerance, diarrhoea after treatment, disturbances of calcium and phosphate balance. In cancer, on the other hand, dairy can be an important source of energy and protein for people at risk of malnutrition - and in practice that consideration decides more often than the epidemiology of risk.

THE DECISION BELONGS TO THE DOCTOR

Nutrition and supplementation during cancer treatment are decided by the treating team together with a clinical dietitian. This page describes the state of knowledge and is not advice for any individual.

Sources

1. [1] World Cancer Research Fund — Dairy and cancer (mocne dowody na zmniejszenie ryzyka raka jelita grubego przez produkty mleczne i suplementy wapnia; dowody na możliwe zwiększenie ryzyka raka gruczołu krokowego; powód braku zalecenia): wcrf.org ↗
2. [2] World Cancer Research Fund — Be a healthy weight: evidence for our recommendations (kontekst: zalecenia profilaktyczne WCRF i kategorie siły dowodów): wcrf.org ↗

WHY THIS ENTRY SITS IN THE DIET CATALOGUE

Body weight is not an ingredient of a menu, but in the WCRF classification it is a factor with stronger evidence behind it than most individual foods. Put differently: HOW MUCH a person eats, and how it is stored, weighs more in the risk calculation than WHAT exactly they eat. That is why this entry stands beside the ones on fibre or processed meat, not instead of them.

WHICH CANCERS THIS CONCERNS

WCRF names thirteen diagnoses for which the link with overweight and obesity is established ^[1]:

• bowel cancer,
• post-menopausal breast cancer,
• gallbladder cancer,
• kidney cancer,
• liver cancer,
• cancers of the mouth, pharynx and larynx,
• oesophageal adenocarcinoma,
• ovarian cancer,
• pancreatic cancer,
• advanced prostate cancer,
• stomach (cardia) cancer,
• womb cancer.

Important distinctions in this list: for breast it is the POST-menopausal period, for oesophagus it is adenocarcinoma (not squamous cell carcinoma), for stomach it is the cardia (not the whole organ), and for prostate it is advanced disease. These qualifications are part of the evidence, and dropping them changes the meaning of the sentence.

PROPOSED MECHANISM

WCRF describes it briefly and cautiously: having too much body fat can cause inflammation and increase the levels of certain hormones in the body, and these factors can increase the risk of cancer cells developing ^[1]. This explains why the list covers hormone-dependent cancers (post-menopausal breast, womb) alongside gastrointestinal ones.

WHAT THE RECOMMENDATION SAYS

WCRF puts it in one sentence: as part of our Cancer Prevention Recommendations, we recommend that people be a healthy weight ^[1]. This is a PUBLIC HEALTH recommendation addressed to a population, not advice for an individual.

WHAT THIS ENTRY DOES NOT SAY — THE PART THAT MATTERS MOST TO A READER WHO IS ILL:

• it does not say that losing weight treats cancer. The data concern the risk of DEVELOPING cancer in healthy people, not the course of a diagnosed disease;
• it does not say that a person with a diagnosis should reduce their weight. During cancer treatment the situation is often the OPPOSITE: malnutrition and unintentional weight loss worsen treatment tolerance and are a separate clinical problem, covered on this site in the entries on nutritional support and cancer cachexia;
• unintentional weight loss is not an achievement but a symptom to report to a doctor;
• it contains no thresholds, no weight-loss diets and no target values for any individual. Those are decided by the physician together with a clinical dietitian who know the patient's nutritional status and comorbidities.

AN HONEST CAVEAT ON THE STRENGTH OF EVIDENCE

These are observational data from population studies. They show a reproducible and strong association, but people of differing body weight also differ in other health behaviours, and part of that influence cannot be fully separated out despite statistical adjustment. WCRF grades this evidence as strong, which denotes consistency of results and a plausible mechanism, not a randomised experiment.

Sources

1. [1] World Cancer Research Fund — Obesity, weight gain and cancer risk (lista trzynastu nowotworow zwiazanych z nadmierna iloscia tkanki tluszczowej; mechanizm zapalny i hormonalny; zalecenie utrzymania prawidlowej masy ciala): wcrf.org ↗

WHAT IARC CONCLUDED

In 2016 an IARC Working Group reviewed more than 1000 observational and experimental studies covering over 20 cancer sites and found the evidence for the carcinogenicity of coffee drinking INADEQUATE. Coffee was moved from Group 2B (possibly carcinogenic), where it had sat since 1991, to Group 3 — not classifiable ^[1]. IARC notes that the earlier classification was a valid reading of the data available in 1991; the change reflects accumulated evidence, not a past error.

WHAT THE WCRF GRADING SAYS

The World Cancer Research Fund and the American Institute for Cancer Research grade the evidence that coffee DECREASES risk as probable for two cancers: hepatocellular carcinoma and cancer of the uterine corpus (endometrium) ^[2]. In the WCRF scheme, "probable" is the second strongest grade, after "convincing". For endometrial cancer the association was seen for both caffeinated and decaffeinated coffee, which argues against attributing it to caffeine alone ^[2].

WHERE THE REAL RISK LIES — TEMPERATURE, NOT THE DRINK. The same IARC evaluation classified drinking VERY HOT beverages in Group 2A (probably carcinogenic to humans) in relation to squamous cell carcinoma of the oesophagus; this concerns beverages consumed at around 65°C and above ^[1]. IARC points out that in most countries coffee and tea are not drunk at such temperatures — the habit is common in parts of South America, Central Asia and East Africa. The practical content of this evaluation therefore differs from the headline "hot drinks cause cancer": what was assessed is temperature, not coffee, tea or mate.

WHAT THESE GRADINGS DO NOT SAY

An IARC classification describes the STRENGTH OF EVIDENCE for carcinogenicity, not the size of the risk — Group 2A does not mean an agent is as hazardous as every other agent in that group. The WCRF grading, in turn, describes associations observed across populations; it does not support the conclusion that drinking coffee will protect a given person from liver cancer, or that someone who does not drink coffee should start. Neither grading concerns the TREATMENT of cancer.

WHAT THIS MEANS FOR A PATIENT IN TREATMENT

The data above concern the risk of developing cancer in the general population, not management during therapy. Caffeine can interact with some medicines and affect sleep, hydration and gastrointestinal symptoms, and dietary advice during chemotherapy, radiotherapy and after surgery is set individually. Decisions about diet during cancer treatment are made by the treating physician together with the care team.

SOURCES:

• ^[1] IARC Monographs Volume 116: Drinking Coffee, Mate, and Very Hot Beverages (2016/2018) — IARC news release and materials.
• ^[2] World Cancer Research Fund / American Institute for Cancer Research, Continuous Update Project — coffee and liver cancer, coffee and endometrial cancer.

WHY PEOPLE TURN TO IT

The alkaline diet and alkaline water are promoted by the media and by sellers as a way to "de-acidify the body" and thereby hinder cancer growth. The premise is that because cancer cells grow less well in an alkaline environment, the pH of the whole body can be shifted by what a person eats and drinks.

WHAT PHYSIOLOGY SAYS

A systematic review published in BMJ Open documented that dietary changes can alter URINE pH but do not change BLOOD pH. Dietary interventions moved urine pH by 0.2–1.2 units, while blood pH changed by only 0.01–0.02 units, because the kidneys excrete acid effectively and maintain systemic pH balance ^[1]. The premise on which the whole idea rests therefore fails at the level of physiology.

WHAT THE EVIDENCE SAYS

The same review identified 8278 citations and reviewed 252 abstracts. Exactly ONE study met the inclusion criteria ^[1].

• No randomised trials were located.
• No study was found that examined alkaline diet or alkaline water for cancer TREATMENT.
• The single included study found no association between dietary acid load and bladder cancer (OR 1.15; 95% CI 0.86–1.55; p = 0.36) ^[1].

WHAT THIS MEANS FOR THE READER

The authors write that despite promotion of the alkaline diet and alkaline water by the media and salespeople, there is almost no actual research to either support or disprove these ideas, and promoting them for cancer prevention or treatment is not justified ^[1]. "No high-quality evidence" is a complete and honest answer here — neither a promise nor silence replaces it.

It is also worth noting what is at stake beyond the water itself: restrictive versions of the alkaline diet limit protein and grain foods, and weight loss and malnutrition during cancer treatment are documented clinical problems ^[2]. Whether and how to modify eating during cancer is decided by the treating physician together with a clinical dietitian.

Sources

1. [1] Fenton TR, Huang T. Systematic review of the association between dietary acid load, alkaline water and cancer. BMJ Open 2016;6:e010438: pmc.ncbi.nlm.nih.gov ↗
2. [2] NCI PDQ — Nutrition in Cancer Care (Health Professional Version): cancer.gov ↗

WHAT THE EVIDENCE SHOWS

A meta-analysis published in Nutrients (2026) on adherence to the Mediterranean diet AFTER a cancer diagnosis, with emphasis on colorectal cancer, included eight studies ^[2]. Six prospective cohort studies (6,697 participants in total) assessed recurrence: higher adherence was associated with a lower risk of recurrence or cancer-specific death (HR 0.83; 95% CI 0.70-0.99; I2 = 49%, i.e. moderate heterogeneity) ^[2]. Two randomised trials (76 participants in total) assessed cancer-related fatigue and found no significant effect (MD 0.29; 95% CI -0.58 to 1.16 — the interval includes zero) ^[2]. The authors themselves note that both results are limited by the small number of studies and methodological heterogeneity, and describe the fatigue evidence as exploratory and statistically imprecise ^[2].

STRENGTH OF EVIDENCE

Moderate and largely observational. That distinction matters most here: in cohort studies, people who eat this way are also more likely to be physically active, not to smoke and to have better access to care — each of which improves prognosis on its own. The result must therefore not be read as "the Mediterranean diet lowers recurrence risk by 17%" ^[2]. For primary prevention the NCI position is more cautious still: population studies have not yet shown definitively that any dietary component causes or protects against cancer ^[1].

WHAT IS WELL DOCUMENTED

One element of this pattern is limiting alcohol, and here the evidence is strong and points the other way: according to the NCI, heavy or regular alcohol consumption INCREASES the risk of cancers of the oral cavity, pharynx, larynx, oesophagus, liver, breast, colon and rectum ^[1]. If one dietary decision has the best-documented bearing on cancer risk, it is limiting alcohol — not selecting "anticancer" foods.

WHO IT SUITS

The pattern aligns with general healthy-eating advice and as such is safe for most people, including during and after cancer treatment. Exceptions need individual assessment: patients with malnutrition or cachexia need an energy- and protein-dense diet rather than a restrictive one, and patients with neutropenia, mucositis, diarrhoea or recent gastrointestinal surgery receive separate advice from their treating team.

WHAT THIS DIET DOES NOT DO

It does not treat cancer and does not replace cancer treatment. None of the studies cited tested the diet as anticancer therapy, and diet is never a reason to delay or modify treatment.

Sources

1. National Cancer Institute — Risk Factors: Diet, cancer.gov 2024: cancer.gov ↗
2. Papamichael D, Felekkis K, Andreou EP — Post-Diagnosis Adherence to the Mediterranean Diet and Cancer Recurrence and Fatigue Outcomes in Cancer Survivors, with Emphasis on Colorectal Cancer: A Systematic Review and Meta-Analysis, Nutrients 2026 (PMID 41829977): europepmc.org ↗

WHAT THE INSTITUTIONS RECOMMEND

In Diet, Nutrition, Physical Activity and Cancer (2018) the World Cancer Research Fund recommends that wholegrains, non-starchy vegetables, fruit and pulses form the basis of the everyday diet. The numerical goals are at least 30 g of dietary fibre from food per day and at least five portions, totalling a minimum of 400 g, of a variety of non-starchy vegetables and fruit per day ^[1]. Non-starchy vegetables are vegetables other than potatoes, sweet potatoes and other starchy tubers.

HOW STRONG IS THE EVIDENCE - THE DISTINCTION THAT USUALLY GETS LOST. WCRF grades its evidence, and for vegetables and fruit it did not award the highest grade:

• evidence in the strong category (probable) applies to the combined effect of non-starchy vegetables and fruit on aerodigestive cancers considered as one group;
• for individual cancer sites the grade falls to limited-suggestive. Non-starchy vegetables: mouth, pharynx and larynx, nasopharynx, oesophagus (adenocarcinoma and squamous cell carcinoma), lung in people who smoke or used to smoke, and oestrogen-receptor-negative breast cancer. Fruit: squamous cell carcinoma of the oesophagus and lung cancer in people who smoke or used to smoke ^[1];
• the limited-suggestive category means the findings are broadly consistent in direction but rarely sufficient to justify recommendations for reducing cancer risk ^[1].

WHAT NCI SAYS ABOUT CRUCIFEROUS VEGETABLES

In its fact sheet on cruciferous vegetables (broccoli, cabbage, Brussels sprouts, cauliflower) the National Cancer Institute states that human studies have shown mixed results ^[2]. For prostate cancer, large cohort studies found little or no association, although some case-control studies suggested a lower risk. For colorectal, lung and breast cancer the picture is similarly inconsistent, and a meta-analysis in breast cancer found no association. NCI presents cruciferous vegetables as part of overall vegetable intake rather than as a separate risk-reducing measure ^[2].

WHY THE RECOMMENDATION IS NEVERTHELESS FIRM

The value of this food group does not rest solely on a direct effect on cancer risk. A diet rich in vegetables, fruit and wholegrains makes it easier to maintain a healthy body weight, and excess body weight is one of the best-documented nutritional risk factors for cancer ^[1]. Separate, strong evidence links dietary fibre and wholegrains to a lower risk of colorectal cancer ^[1] - this catalogue covers that in its own entry.

WHAT THIS ENTRY DOES NOT SAY

There is no evidence that vegetables or fruit treat cancer or replace any form of treatment. Nor is there a basis for singling out any individual product as anticancer - the evidence concerns the overall dietary pattern rather than single components. Nutrition during cancer treatment, in particular in malnutrition, swallowing disorders, neutropenia or after gastrointestinal surgery, is determined by the treating physician together with a clinical dietitian.

WHAT THE RECOMMENDATION COVERS

In Diet, Nutrition, Physical Activity and Cancer (2018) the World Cancer Research Fund frames it as limiting consumption of processed foods high in fat, starches or sugars, including foods described as fast foods ^[1]. It concerns energy-dense products that make it easy to exceed energy requirements, rather than one category of dish or any particular restaurant chain.

HOW STRONG IS THE EVIDENCE

• Strong evidence: diets containing greater amounts of fast foods and other processed foods are a cause of weight gain, overweight and obesity, because they increase the risk of excess energy intake ^[1].
• Probable evidence: consuming fast foods is a cause of weight gain, overweight and obesity; the same applies to a Western-type diet as an overall dietary pattern ^[1].
• Probable evidence, this time for CANCER directly: a high dietary glycaemic load is a cause of endometrial cancer ^[1].

WHY THE RECOMMENDATION STILL MATTERS ALTHOUGH THE LINK IS INDIRECT. For most cancers the effect of this food group has not been demonstrated directly - it runs through body weight. That indirect route is not a weak one: excess body weight is among the best-documented nutritional risk factors for cancer and is linked to more than a dozen diagnoses. This catalogue covers it in a separate entry that lists the specific cancers together with their qualifications (for example, breast cancer only after the menopause). Limiting highly processed foods is therefore a tool for maintaining body weight, not a standalone anticancer measure.

WHAT THIS ENTRY DOES NOT SAY

There is no evidence that a single fast-food meal increases cancer risk, or that avoiding one protects against the disease. The recommendation concerns a sustained dietary pattern, not isolated episodes. The opposite situation deserves separate attention: in patients with malnutrition or cancer cachexia, restricting energy intake can be harmful, and nutrition during cancer treatment is determined by the treating physician together with a clinical dietitian - this catalogue describes prevention at population level, not management of an individual person.